113 related articles for article (PubMed ID: 37843334)
1. Is HPV-negative cervical carcinoma a different type of cervical cancer?
Kulhan M; Bilgi A; Avci F; Ucar MG; Celik C; Kulhan NG
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9205-9212. PubMed ID: 37843334
[TBL] [Abstract][Full Text] [Related]
2. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
[TBL] [Abstract][Full Text] [Related]
3. HPV-negative tumors of the uterine cervix.
Nicolás I; Marimon L; Barnadas E; Saco A; Rodríguez-Carunchio L; Fusté P; Martí C; Rodriguez-Trujillo A; Torne A; Del Pino M; Ordi J
Mod Pathol; 2019 Jul; 32(8):1189-1196. PubMed ID: 30911077
[TBL] [Abstract][Full Text] [Related]
4. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
Li T; Chen S; Li X; Wu Z; Zhao Y; Cui J; Liu B; Chen F; Zhang X; Qiao Y; Chen W
Virol J; 2023 Jun; 20(1):116. PubMed ID: 37280665
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix.
Nicolás I; Saco A; Barnadas E; Marimon L; Rakislova N; Fusté P; Rovirosa A; Gaba L; Buñesch L; Gil-Ibañez B; Pahisa J; Díaz-Feijoo B; Torne A; Ordi J; Del Pino M
Mod Pathol; 2020 Jan; 33(1):128-137. PubMed ID: 31492932
[TBL] [Abstract][Full Text] [Related]
6. Metatranscriptome analysis in human papillomavirus negative cervical cancers.
Ure AE; Lagheden C; Arroyo Mühr LS
Sci Rep; 2022 Sep; 12(1):15062. PubMed ID: 36064569
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix.
Wang HL; Lu DW
Am J Surg Pathol; 2004 Jul; 28(7):901-8. PubMed ID: 15223960
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
[TBL] [Abstract][Full Text] [Related]
10. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
Ngamkham J; Boonmark K; Phansri T
Asian Pac J Cancer Prev; 2016; 17(3):1129-34. PubMed ID: 27039737
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
[TBL] [Abstract][Full Text] [Related]
12. Cervical small cell carcinoma frequently presented in multiple high risk HPV infection and often associated with other type of epithelial tumors.
Li P; Ma J; Zhang X; Guo Y; Liu Y; Li X; Zhao D; Wang Z
Diagn Pathol; 2018 May; 13(1):31. PubMed ID: 29788963
[TBL] [Abstract][Full Text] [Related]
13. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
14. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
Li Y; Liu J; Gong L; Sun X; Long W
Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
[No Abstract] [Full Text] [Related]
16. Joint detection of multiple HPV-testing technologies and evaluation of clinicopathological characteristics discriminate between HPV-independent and low-copy HPV-associated cervical squamous cell carcinoma (CSCC) -an analysis of 3869 cases.
Lu L; Liu T; Wang S; Li J; Zhang F; Ning Y; Wang Y
Gynecol Oncol; 2023 Mar; 170():59-69. PubMed ID: 36630845
[TBL] [Abstract][Full Text] [Related]
17. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
19. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
[TBL] [Abstract][Full Text] [Related]
20. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
